Reistone Biopharma Company Limited (Reistone Biopharma) recently announced the appointment of Sam Ma as Vice President, Business Innovation & Alliance. He will be based in Shanghai and report to Min Irwin, CEO.
Sam earned his Executive MBA from Tsinghua University in 2015. In 1992, Sam graduated with bachelor’s degree in biotechnology from Fu Dan University. In 1993, he went to Russia as a visiting scholar. Before joining pharmaceutical industry, Sam joined the Chinese Academy of Sciences and was engaged in drug research and development.
Sam Ma has more than 25 years of experience working in the pharmaceutical industry:
• 2017.01-2020.11, Vice President and General Manager of Business Division of Jiangsu Aidea Pharmaceutical Co., LTD., and participated in listing of the company on stock Kechuang Board • 2010.05-2016.12, Head of Business Development of Techpool, and participated in the merger and acquisition transaction between Techpool and Takeda; • 2007.08-2010.04, Director of Strategic Planning in Eisai (China) Pharmaceutical Company • 1995.01-2007.07, took various roles of increasing responsibilities at GlaxoSmithKline in business commercial in different carrier stage, including the head of sales, marketing and strategy.